PMG
RMD icon

ProVise Management Group’s ResMed RMD Stock Holding History

ProVise Management Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,468
Closed -$623K – 318
2018
Q4 		$623K Sell
5,468
-546
-9% -$58.5K 0.1% 168
2018
Q3 		$694K Buy
6,014
+110
+2% +$12K 0.09% 178
2018
Q2 		$612 Buy
+5,904
New +$597K 0.05% 201

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ProVise Management Group's RMD Position: Q1 2019 in Review

ProVise Management Group sold out of ResMed (RMD) in Q1 2019, closing a stake of 5,468 shares — an estimated $623K sold.

ProVise Management Group first reported a position in RMD in Q2 2018 and held it in 3 quarters. The position peaked at $694K in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

  • ProVise Management Group reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
  • ProVise Management Group sold 5,468 ResMed shares in Q1 2019, an estimated $623K.
  • ProVise Management Group first reported a position in ResMed in Q2 2018 and held it in 3 quarters.
  • ProVise Management Group's ResMed position peaked at $694K in Q3 2018.
  • 477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on ProVise Management Group's 13F filing for Q1 2019, filed 13 May 2019.